The global Gout Drugs market was valued at US$ 3874 million in 2025 and is anticipated to reach US$ 6391 million by 2032, at a CAGR of 7.5% from 2026 to 2032.

Gout Drugs Market

Gout drugs refer to pharmaceutical agents used for the treatment and management of gout and hyperuricemia. Their primary mechanisms include reducing uric acid production, enhancing uric acid excretion, and alleviating acute inflammatory responses. Based on therapeutic mechanisms, gout drugs are generally divided into three major categories: xanthine oxidase inhibitors (e.g., allopurinol, febuxostat), uricosuric agents that promote uric acid excretion (e.g., probenecid, lesinurad), and anti-inflammatory drugs for acute gout attacks (e.g., colchicine, NSAIDs). In recent years, with the rising prevalence of metabolic syndromes, hypertension, and diabetes, the incidence of gout has increased globally, driving rapid growth in treatment demand. Meanwhile, the emergence of biologics and small-molecule targeted therapies has revolutionized treatment paradigms, shifting gout management toward precision and individualized therapy. The average gross profit margin in this industry is 60%.

The global gout drug market is expanding under multiple structural opportunities. The westernization of lifestyles and changing dietary patterns have made gout a major health burden in both developed and emerging markets, creating a vast patient base for pharmaceutical companies. Regulatory agencies’ increasing attention to gout and related comorbidities has accelerated drug approvals and reimbursement coverage. Leading pharmaceutical firms are investing in novel targets such as URAT1 and IL-1β, as well as long-acting formulations that improve treatment adherence. Moreover, digital health technologies—such as remote monitoring and AI-assisted diagnosis—are transforming gout management into an era of “precision monitoring and smart intervention.”

The gout drug market faces intensified competition and several key challenges. The expiration of patents for conventional drugs has led to a surge of generics, intensifying price competition and reducing profit margins. Safety concerns surrounding certain innovative drugs, such as febuxostat, have prompted regulatory reassessments and market restrictions. Poor long-term patient adherence, especially among asymptomatic hyperuricemia patients, limits market penetration. Additionally, fluctuations in the global API supply chain and stricter regulatory oversight have raised production and compliance costs.

Clinicians and patients are shifting focus from merely controlling pain to managing uric acid levels and preventing relapses. The need for chronic disease management is expanding the long-term treatment population. Meanwhile, the boundary between prescription and OTC products is blurring, with online consultation platforms and chronic disease management apps emerging as new sales channels. Regionally, Asia and the Middle East—driven by dietary habits and genetic factors—represent the fastest-growing markets, while North America and Europe focus on innovative and combination therapies.

The upstream segment of gout drugs mainly involves organic synthesis intermediates, APIs, and excipients. Xanthine oxidase inhibitors rely on nitrogen-containing heterocycles and pyrimidine derivatives, while uricosuric agents require high-purity organic acids and aromatic compounds. The concentration of API production in China and India offers cost advantages but also introduces geopolitical and environmental risks. Increasing environmental regulations and stricter GMP requirements are driving upstream firms to adopt greener synthesis routes and technological upgrades to ensure reliable supply for global pharmaceutical manufacturers.

This report delivers a comprehensive overview of the global Gout Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gout Drugs. The Gout Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Gout Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Gout Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Gout Drugs Market Report

Report Metric	Details
Report Name	Gout Drugs Market
Accounted market size in 2025	US$ 3874 million
Forecasted market size in 2032	US$ 6391 million
CAGR	7.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Febuxostat Benzbromarone NSAIDs Colchicine Glucocorticoids Allopurinol Other
Segment by Application	Acute Gout Chronic Gout
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda Pharmaceuticals, Hermann Germany, Aspen, Teijin Pharma, Horizon Pharmaceuticals, Novartis, Wanbang Biopharmaceuticals, Hengrui Medicine, London Reddy, East Sunshine Pharmaceuticals, Kunming Pharmaceuticals, Heilongjiang Auridanide, Jingde Pharmaceutical Factory, Tianjie Biopharmaceuticals, Shanghai Pharmaceuticals, Chengdu Taihe Health
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Gout Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Gout Drugs Market growing?

Ans: The Gout Drugs Market witnessing a CAGR of 7.5% during the forecast period 2026-2032.

What is the Gout Drugs Market size in 2032?

Ans: The Gout Drugs Market size in 2032 will be US$ 6391 million.

Who are the main players in the Gout Drugs Market report?

Ans: The main players in the Gout Drugs Market are Takeda Pharmaceuticals, Hermann Germany, Aspen, Teijin Pharma, Horizon Pharmaceuticals, Novartis, Wanbang Biopharmaceuticals, Hengrui Medicine, London Reddy, East Sunshine Pharmaceuticals, Kunming Pharmaceuticals, Heilongjiang Auridanide, Jingde Pharmaceutical Factory, Tianjie Biopharmaceuticals, Shanghai Pharmaceuticals, Chengdu Taihe Health

What are the Application segmentation covered in the Gout Drugs Market report?

Ans: The Applications covered in the Gout Drugs Market report are Acute Gout, Chronic Gout

What are the Type segmentation covered in the Gout Drugs Market report?

Ans: The Types covered in the Gout Drugs Market report are Febuxostat, Benzbromarone, NSAIDs, Colchicine, Glucocorticoids, Allopurinol, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gout Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Febuxostat

1.2.3 Benzbromarone

1.2.4 NSAIDs

1.2.5 Colchicine

1.2.6 Glucocorticoids

1.2.7 Allopurinol

1.2.8 Other

1.3 Market by Application

1.3.1 Global Gout Drugs Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Acute Gout

1.3.3 Chronic Gout

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gout Drugs Market Perspective (2021–2032)

2.2 Global Gout Drugs Growth Trends by Region

2.2.1 Global Gout Drugs Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Gout Drugs Historic Market Size by Region (2021–2026)

2.2.3 Gout Drugs Forecasted Market Size by Region (2027–2032)

2.3 Gout Drugs Market Dynamics

2.3.1 Gout Drugs Industry Trends

2.3.2 Gout Drugs Market Drivers

2.3.3 Gout Drugs Market Challenges

2.3.4 Gout Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gout Drugs Players by Revenue

3.1.1 Global Top Gout Drugs Players by Revenue (2021–2026)

3.1.2 Global Gout Drugs Revenue Market Share by Players (2021–2026)

3.2 Global Top Gout Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Gout Drugs Revenue

3.4 Global Gout Drugs Market Concentration Ratio

3.4.1 Global Gout Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gout Drugs Revenue in 2025

3.5 Global Key Players of Gout Drugs Head Offices and Areas Served

3.6 Global Key Players of Gout Drugs, Products and Applications

3.7 Global Key Players of Gout Drugs, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Gout Drugs Breakdown Data by Type

4.1 Global Gout Drugs Historic Market Size by Type (2021–2026)

4.2 Global Gout Drugs Forecasted Market Size by Type (2027–2032)

5 Gout Drugs Breakdown Data by Application

5.1 Global Gout Drugs Historic Market Size by Application (2021–2026)

5.2 Global Gout Drugs Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Gout Drugs Market Size (2021–2032)

6.2 North America Gout Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Gout Drugs Market Size by Country (2021–2026)

6.4 North America Gout Drugs Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gout Drugs Market Size (2021–2032)

7.2 Europe Gout Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Gout Drugs Market Size by Country (2021–2026)

7.4 Europe Gout Drugs Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Gout Drugs Market Size (2021–2032)

8.2 Asia-Pacific Gout Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Gout Drugs Market Size by Region (2021–2026)

8.4 Asia-Pacific Gout Drugs Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Gout Drugs Market Size (2021–2032)

9.2 Latin America Gout Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Gout Drugs Market Size by Country (2021–2026)

9.4 Latin America Gout Drugs Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gout Drugs Market Size (2021–2032)

10.2 Middle East & Africa Gout Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Gout Drugs Market Size by Country (2021–2026)

10.4 Middle East & Africa Gout Drugs Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Takeda Pharmaceuticals

11.1.1 Takeda Pharmaceuticals Company Details

11.1.2 Takeda Pharmaceuticals Business Overview

11.1.3 Takeda Pharmaceuticals Gout Drugs Introduction

11.1.4 Takeda Pharmaceuticals Revenue in Gout Drugs Business (2021–2026)

11.1.5 Takeda Pharmaceuticals Recent Development

11.2 Hermann Germany

11.2.1 Hermann Germany Company Details

11.2.2 Hermann Germany Business Overview

11.2.3 Hermann Germany Gout Drugs Introduction

11.2.4 Hermann Germany Revenue in Gout Drugs Business (2021–2026)

11.2.5 Hermann Germany Recent Development

11.3 Aspen

11.3.1 Aspen Company Details

11.3.2 Aspen Business Overview

11.3.3 Aspen Gout Drugs Introduction

11.3.4 Aspen Revenue in Gout Drugs Business (2021–2026)

11.3.5 Aspen Recent Development

11.4 Teijin Pharma

11.4.1 Teijin Pharma Company Details

11.4.2 Teijin Pharma Business Overview

11.4.3 Teijin Pharma Gout Drugs Introduction

11.4.4 Teijin Pharma Revenue in Gout Drugs Business (2021–2026)

11.4.5 Teijin Pharma Recent Development

11.5 Horizon Pharmaceuticals

11.5.1 Horizon Pharmaceuticals Company Details

11.5.2 Horizon Pharmaceuticals Business Overview

11.5.3 Horizon Pharmaceuticals Gout Drugs Introduction

11.5.4 Horizon Pharmaceuticals Revenue in Gout Drugs Business (2021–2026)

11.5.5 Horizon Pharmaceuticals Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Gout Drugs Introduction

11.6.4 Novartis Revenue in Gout Drugs Business (2021–2026)

11.6.5 Novartis Recent Development

11.7 Wanbang Biopharmaceuticals

11.7.1 Wanbang Biopharmaceuticals Company Details

11.7.2 Wanbang Biopharmaceuticals Business Overview

11.7.3 Wanbang Biopharmaceuticals Gout Drugs Introduction

11.7.4 Wanbang Biopharmaceuticals Revenue in Gout Drugs Business (2021–2026)

11.7.5 Wanbang Biopharmaceuticals Recent Development

11.8 Hengrui Medicine

11.8.1 Hengrui Medicine Company Details

11.8.2 Hengrui Medicine Business Overview

11.8.3 Hengrui Medicine Gout Drugs Introduction

11.8.4 Hengrui Medicine Revenue in Gout Drugs Business (2021–2026)

11.8.5 Hengrui Medicine Recent Development

11.9 London Reddy

11.9.1 London Reddy Company Details

11.9.2 London Reddy Business Overview

11.9.3 London Reddy Gout Drugs Introduction

11.9.4 London Reddy Revenue in Gout Drugs Business (2021–2026)

11.9.5 London Reddy Recent Development

11.10 East Sunshine Pharmaceuticals

11.10.1 East Sunshine Pharmaceuticals Company Details

11.10.2 East Sunshine Pharmaceuticals Business Overview

11.10.3 East Sunshine Pharmaceuticals Gout Drugs Introduction

11.10.4 East Sunshine Pharmaceuticals Revenue in Gout Drugs Business (2021–2026)

11.10.5 East Sunshine Pharmaceuticals Recent Development

11.11 Kunming Pharmaceuticals

11.11.1 Kunming Pharmaceuticals Company Details

11.11.2 Kunming Pharmaceuticals Business Overview

11.11.3 Kunming Pharmaceuticals Gout Drugs Introduction

11.11.4 Kunming Pharmaceuticals Revenue in Gout Drugs Business (2021–2026)

11.11.5 Kunming Pharmaceuticals Recent Development

11.12 Heilongjiang Auridanide

11.12.1 Heilongjiang Auridanide Company Details

11.12.2 Heilongjiang Auridanide Business Overview

11.12.3 Heilongjiang Auridanide Gout Drugs Introduction

11.12.4 Heilongjiang Auridanide Revenue in Gout Drugs Business (2021–2026)

11.12.5 Heilongjiang Auridanide Recent Development

11.13 Jingde Pharmaceutical Factory

11.13.1 Jingde Pharmaceutical Factory Company Details

11.13.2 Jingde Pharmaceutical Factory Business Overview

11.13.3 Jingde Pharmaceutical Factory Gout Drugs Introduction

11.13.4 Jingde Pharmaceutical Factory Revenue in Gout Drugs Business (2021–2026)

11.13.5 Jingde Pharmaceutical Factory Recent Development

11.14 Tianjie Biopharmaceuticals

11.14.1 Tianjie Biopharmaceuticals Company Details

11.14.2 Tianjie Biopharmaceuticals Business Overview

11.14.3 Tianjie Biopharmaceuticals Gout Drugs Introduction

11.14.4 Tianjie Biopharmaceuticals Revenue in Gout Drugs Business (2021–2026)

11.14.5 Tianjie Biopharmaceuticals Recent Development

11.15 Shanghai Pharmaceuticals

11.15.1 Shanghai Pharmaceuticals Company Details

11.15.2 Shanghai Pharmaceuticals Business Overview

11.15.3 Shanghai Pharmaceuticals Gout Drugs Introduction

11.15.4 Shanghai Pharmaceuticals Revenue in Gout Drugs Business (2021–2026)

11.15.5 Shanghai Pharmaceuticals Recent Development

11.16 Chengdu Taihe Health

11.16.1 Chengdu Taihe Health Company Details

11.16.2 Chengdu Taihe Health Business Overview

11.16.3 Chengdu Taihe Health Gout Drugs Introduction

11.16.4 Chengdu Taihe Health Revenue in Gout Drugs Business (2021–2026)

11.16.5 Chengdu Taihe Health Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceuticals

Hermann Germany

Aspen

Teijin Pharma

Horizon Pharmaceuticals

Novartis

Wanbang Biopharmaceuticals

Hengrui Medicine

London Reddy

East Sunshine Pharmaceuticals

Kunming Pharmaceuticals

Heilongjiang Auridanide

Jingde Pharmaceutical Factory

Tianjie Biopharmaceuticals

Shanghai Pharmaceuticals

Chengdu Taihe Health

List of Tables

Table 1. Global Gout Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Febuxostat

Table 3. Key Players of Benzbromarone

Table 4. Key Players of NSAIDs

Table 5. Key Players of Colchicine

Table 6. Key Players of Glucocorticoids

Table 7. Key Players of Allopurinol

Table 8. Key Players of Other

Table 9. Global Gout Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Gout Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 11. Global Gout Drugs Market Size by Region (US$ Million), 2021–2026

Table 12. Global Gout Drugs Market Share by Region (2021–2026)

Table 13. Global Gout Drugs Forecasted Market Size by Region (US$ Million), 2027–2032

Table 14. Global Gout Drugs Market Share by Region (2027–2032)

Table 15. Gout Drugs Market Trends

Table 16. Gout Drugs Market Drivers

Table 17. Gout Drugs Market Challenges

Table 18. Gout Drugs Market Restraints

Table 19. Global Gout Drugs Revenue by Players (US$ Million), 2021–2026

Table 20. Global Gout Drugs Market Share by Players (2021–2026)

Table 21. Global Top Gout Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gout Drugs Revenue, 2025

Table 22. Ranking of Global Top Gout Drugs Companies by Revenue (US$ Million) in 2025

Table 23. Global 5 Largest Players Market Share by Gout Drugs Revenue (CR5 and HHI), 2021–2026

Table 24. Global Key Players of Gout Drugs, Headquarters and Area Served

Table 25. Global Key Players of Gout Drugs, Products and Applications

Table 26. Global Key Players of Gout Drugs, Date of General Availability (GA)

Table 27. Mergers and Acquisitions, Expansion Plans

Table 28. Global Gout Drugs Market Size by Type (US$ Million), 2021–2026

Table 29. Global Gout Drugs Revenue Market Share by Type (2021–2026)

Table 30. Global Gout Drugs Forecasted Market Size by Type (US$ Million), 2027–2032

Table 31. Global Gout Drugs Revenue Market Share by Type (2027–2032)

Table 32. Global Gout Drugs Market Size by Application (US$ Million), 2021–2026

Table 33. Global Gout Drugs Revenue Market Share by Application (2021–2026)

Table 34. Global Gout Drugs Forecasted Market Size by Application (US$ Million), 2027–2032

Table 35. Global Gout Drugs Revenue Market Share by Application (2027–2032)

Table 36. North America Gout Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. North America Gout Drugs Market Size by Country (US$ Million), 2021–2026

Table 38. North America Gout Drugs Market Size by Country (US$ Million), 2027–2032

Table 39. Europe Gout Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. Europe Gout Drugs Market Size by Country (US$ Million), 2021–2026

Table 41. Europe Gout Drugs Market Size by Country (US$ Million), 2027–2032

Table 42. Asia-Pacific Gout Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 43. Asia-Pacific Gout Drugs Market Size by Region (US$ Million), 2021–2026

Table 44. Asia-Pacific Gout Drugs Market Size by Region (US$ Million), 2027–2032

Table 45. Latin America Gout Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Latin America Gout Drugs Market Size by Country (US$ Million), 2021–2026

Table 47. Latin America Gout Drugs Market Size by Country (US$ Million), 2027–2032

Table 48. Middle East & Africa Gout Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Middle East & Africa Gout Drugs Market Size by Country (US$ Million), 2021–2026

Table 50. Middle East & Africa Gout Drugs Market Size by Country (US$ Million), 2027–2032

Table 51. Takeda Pharmaceuticals Company Details

Table 52. Takeda Pharmaceuticals Business Overview

Table 53. Takeda Pharmaceuticals Gout Drugs Product

Table 54. Takeda Pharmaceuticals Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 55. Takeda Pharmaceuticals Recent Development

Table 56. Hermann Germany Company Details

Table 57. Hermann Germany Business Overview

Table 58. Hermann Germany Gout Drugs Product

Table 59. Hermann Germany Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 60. Hermann Germany Recent Development

Table 61. Aspen Company Details

Table 62. Aspen Business Overview

Table 63. Aspen Gout Drugs Product

Table 64. Aspen Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 65. Aspen Recent Development

Table 66. Teijin Pharma Company Details

Table 67. Teijin Pharma Business Overview

Table 68. Teijin Pharma Gout Drugs Product

Table 69. Teijin Pharma Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 70. Teijin Pharma Recent Development

Table 71. Horizon Pharmaceuticals Company Details

Table 72. Horizon Pharmaceuticals Business Overview

Table 73. Horizon Pharmaceuticals Gout Drugs Product

Table 74. Horizon Pharmaceuticals Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 75. Horizon Pharmaceuticals Recent Development

Table 76. Novartis Company Details

Table 77. Novartis Business Overview

Table 78. Novartis Gout Drugs Product

Table 79. Novartis Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 80. Novartis Recent Development

Table 81. Wanbang Biopharmaceuticals Company Details

Table 82. Wanbang Biopharmaceuticals Business Overview

Table 83. Wanbang Biopharmaceuticals Gout Drugs Product

Table 84. Wanbang Biopharmaceuticals Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 85. Wanbang Biopharmaceuticals Recent Development

Table 86. Hengrui Medicine Company Details

Table 87. Hengrui Medicine Business Overview

Table 88. Hengrui Medicine Gout Drugs Product

Table 89. Hengrui Medicine Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 90. Hengrui Medicine Recent Development

Table 91. London Reddy Company Details

Table 92. London Reddy Business Overview

Table 93. London Reddy Gout Drugs Product

Table 94. London Reddy Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 95. London Reddy Recent Development

Table 96. East Sunshine Pharmaceuticals Company Details

Table 97. East Sunshine Pharmaceuticals Business Overview

Table 98. East Sunshine Pharmaceuticals Gout Drugs Product

Table 99. East Sunshine Pharmaceuticals Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 100. East Sunshine Pharmaceuticals Recent Development

Table 101. Kunming Pharmaceuticals Company Details

Table 102. Kunming Pharmaceuticals Business Overview

Table 103. Kunming Pharmaceuticals Gout Drugs Product

Table 104. Kunming Pharmaceuticals Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 105. Kunming Pharmaceuticals Recent Development

Table 106. Heilongjiang Auridanide Company Details

Table 107. Heilongjiang Auridanide Business Overview

Table 108. Heilongjiang Auridanide Gout Drugs Product

Table 109. Heilongjiang Auridanide Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 110. Heilongjiang Auridanide Recent Development

Table 111. Jingde Pharmaceutical Factory Company Details

Table 112. Jingde Pharmaceutical Factory Business Overview

Table 113. Jingde Pharmaceutical Factory Gout Drugs Product

Table 114. Jingde Pharmaceutical Factory Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 115. Jingde Pharmaceutical Factory Recent Development

Table 116. Tianjie Biopharmaceuticals Company Details

Table 117. Tianjie Biopharmaceuticals Business Overview

Table 118. Tianjie Biopharmaceuticals Gout Drugs Product

Table 119. Tianjie Biopharmaceuticals Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 120. Tianjie Biopharmaceuticals Recent Development

Table 121. Shanghai Pharmaceuticals Company Details

Table 122. Shanghai Pharmaceuticals Business Overview

Table 123. Shanghai Pharmaceuticals Gout Drugs Product

Table 124. Shanghai Pharmaceuticals Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 125. Shanghai Pharmaceuticals Recent Development

Table 126. Chengdu Taihe Health Company Details

Table 127. Chengdu Taihe Health Business Overview

Table 128. Chengdu Taihe Health Gout Drugs Product

Table 129. Chengdu Taihe Health Revenue in Gout Drugs Business (US$ Million), 2021–2026

Table 130. Chengdu Taihe Health Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. Authors List of This Report

List of Figures

Figure 1. Gout Drugs Picture

Figure 2. Global Gout Drugs Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Gout Drugs Market Share by Type: 2025 vs 2032

Figure 4. Febuxostat Features

Figure 5. Benzbromarone Features

Figure 6. NSAIDs Features

Figure 7. Colchicine Features

Figure 8. Glucocorticoids Features

Figure 9. Allopurinol Features

Figure 10. Other Features

Figure 11. Global Gout Drugs Market Size by Application (US$ Million), 2021–2032

Figure 12. Global Gout Drugs Market Share by Application: 2025 vs 2032

Figure 13. Acute Gout Case Studies

Figure 14. Chronic Gout Case Studies

Figure 15. Gout Drugs Report Years Considered

Figure 16. Global Gout Drugs Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 17. Global Gout Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Gout Drugs Market Share by Region: 2025 vs 2032

Figure 19. Global Gout Drugs Market Share by Players in 2025

Figure 20. Global Gout Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. The Top 10 and 5 Players Market Share by Gout Drugs Revenue in 2025

Figure 22. North America Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. North America Gout Drugs Market Share by Country (2021–2032)

Figure 24. United States Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Canada Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Gout Drugs Market Share by Country (2021–2032)

Figure 28. Germany Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. France Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. U.K. Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Italy Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Russia Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Ireland Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Gout Drugs Market Share by Region (2021–2032)

Figure 36. China Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Japan Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. South Korea Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Southeast Asia Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. India Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Australia & New Zealand Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Gout Drugs Market Share by Country (2021–2032)

Figure 44. Mexico Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Brazil Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Gout Drugs Market Share by Country (2021–2032)

Figure 48. Israel Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Saudi Arabia Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. UAE Gout Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Takeda Pharmaceuticals Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 52. Hermann Germany Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 53. Aspen Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 54. Teijin Pharma Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 55. Horizon Pharmaceuticals Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 56. Novartis Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 57. Wanbang Biopharmaceuticals Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 58. Hengrui Medicine Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 59. London Reddy Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 60. East Sunshine Pharmaceuticals Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 61. Kunming Pharmaceuticals Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 62. Heilongjiang Auridanide Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 63. Jingde Pharmaceutical Factory Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 64. Tianjie Biopharmaceuticals Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 65. Shanghai Pharmaceuticals Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 66. Chengdu Taihe Health Revenue Growth Rate in Gout Drugs Business (2021–2026)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drugs of Abuse Testing Market Research Report 2024

Global Autoimmune Diseases Treatment Market Research Report 2024

Global Cholesterol Lowering Drugs Market Research Report 2024

Global CGT Drugs Market Research Report 2025

Global Chronic Kidney Disease Drugs Market Research Report 2025

Global Tauopathies Treatment Market Research Report 2025

Global Diagnostic Guidewire Market Research Report 2024

Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Treatment Planning Software Market Research Report 2025

Global Coding and Marking for Pharmaceuticals and Consumer Products Market Research Report 2024

Global Weekly Pill Organizer Market Research Report 2025

Global Ant Killer Market Research Report 2024

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Global Combination Therapy Drug Market Research Report 2025

Global Pharmaceutical Validation Services Market Research Report 2025

Global Pharmaceutical Asset Management Market Research Report 2025

Global Cardiovascular Disease Nursing Drugs Market Research Report 2025

Global Urinary Tract Infection Therapeutics Market Research Report 2025

Global Peptic Ulcers Treatment Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions